RBC Life Sciences, Inc.
RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.
DitchCarbon Score
How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RBC Life Sciences, Inc.'s score of 20 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RBC Life Sciences, Inc.'s reported carbon emissions
In 2022, RBC Life Sciences, Inc. reported total carbon emissions of approximately 65,577,000 kg CO2e from Scope 1 and Scope 2 sources, alongside 11,920,000 kg CO2e from Scope 3 emissions. This marked a reduction in Scope 1 emissions from about 21,089,000 kg CO2e in 2021 and a decrease in Scope 2 emissions from approximately 70,440,000 kg CO2e in the same year. Over the years, RBC has demonstrated a commitment to reducing its carbon footprint, with emissions from Scope 1 decreasing from about 25,735,000 kg CO2e in 2019 to 22,840,000 kg CO2e in 2022. Similarly, Scope 2 emissions have seen a decline from approximately 89,769,000 kg CO2e in 2019 to 65,577,000 kg CO2e in 2022. However, there are no specific reduction targets or initiatives disclosed in their climate commitments. RBC Life Sciences, Inc. continues to monitor and report its emissions across all three scopes, reflecting an ongoing commitment to transparency and accountability in its climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Scope 1 | 24,821,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 102,009,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 31,741,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RBC Life Sciences, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
